AD biomarkers are now recommended for symptomatic patients within a comprehensive clinical evaluation. High-performance p-tau217 assays provide cost-effective diagnostics comparable to cerebrospinal fluid and PET. International...
Scientists at the University of Cambridge have developed an artificial intelligence tool that can predict whether people with early signs of dementia will remain stable or...
Kathrin LaFaver, MD Kathrin LaFaver, MD, a neurologist and lifestyle medicine specialist from Saratoga Springs, New York, interviewed Dean Ornish, MD, the founder and president of the...
A recent study published in the journal Nature MedicineResearchers have developed and validated an artificial intelligence (AI) model that uses multimodal data to accurately distinguish between...
Much of the discussion about the upcoming US presidential election Age IssuesDonald Trump is 78 years old and Joe Biden is 81 years old. So that...
Study population We collected demographics, personal and family history, laboratory results, findings from the physical/neurological exams, medications, neuropsychological tests, and functional assessments as well as multisequence...
Recent Comments